Seraxis Announces Appointment of Chief Medical Officer, Dr. Paul Strumph
![Dr Paul Strumph](https://nationalstemcelltherapy.com/wp-content/uploads/2022/08/Dr-Paul-Strumph.jpg)
GERMANTOWN, Md., Aug. 30, 2022 (GLOBE NEWSWIRE) — The regenerative medicine company Seraxis Inc. today announced the appointment of Paul Strumph, M.D. as Chief Medical Officer. Dr. Strumph is an endocrinology and diabetes care and research specialist with a successful career of bringing anti-diabetes treatments to market. He will drive the company’s clinical and medical […]